Related Experiment Video
Updated: Jun 1, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Müllerian adenosarcomas with unusual growth patterns: staging issues.
Blaise Alexander Clarke1, Anna Marie Mulligan, Julie A Irving
1Department of Pathology, University Health Network, Toronto, Ontario, Canada. blaise.clarke@uhn.on.ca
Summary
Uterine adenosarcomas with rare presentations challenge current staging systems. This study proposes a descriptive reporting strategy and nomenclature for these unusual mixed Müllerian neoplasms to improve data collection and guide future evidence-based staging.
Area of Science:
- Gynecologic Oncology
- Pathology
- Tumor Staging
Background:
- Uterine adenosarcomas are rare mixed Müllerian neoplasms originating in the uterus.
- A new Federation of International Gynecologic Organization (FIGO) staging system has been implemented, improving upon previous generic applications.
- Existing staging systems lack specific guidelines for adenosarcomas with unusual presentations.
Observation:
- Report of three uterine adenosarcomas exhibiting rare features.
- Case 1: Adenosarcoma in eutopic endometrium with adenomyosis, no myometrial invasion.
- Case 2: Adenosarcoma originating in a mural adenomyoma without endometrial involvement.
- Case 3: Synchronous endometrial and extrauterine (peritoneal) adenosarcomas.
Findings:
- The new FIGO staging system, like the old, does not provide specific guidelines for these unusual adenosarcoma cases.
- Insufficient evidence exists to definitively stage these rare adenosarcoma variants.
- A descriptive reporting strategy and standardized nomenclature are proposed for these unusual cases.
Implications:
- Standardized reporting will facilitate reliable data collection for rare uterine adenosarcomas.
- This approach aims to enable the development of an evidence-based staging system for these challenging presentations.
- Improved data collection is crucial for advancing the understanding and management of uterine adenosarcomas.
